Media coverage about Hansen Medical (NASDAQ:HNSN) has trended somewhat positive this week, Accern Sentiment reports. The research group identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Hansen Medical earned a media sentiment score of 0.18 on Accern’s scale. Accern also assigned media headlines about the medical equipment provider an impact score of 45.8743352071272 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Shares of Hansen Medical stock remained flat at $$3.99 during trading on Friday. Hansen Medical has a 52-week low of $1.28 and a 52-week high of $9.10.
About Hansen Medical
Hansen Medical, Inc is engaged in the development and marketing of medical devices. The Company develops, manufactures and sells a range of medical robotics designed for positioning, manipulation and stable control of catheters and catheter-based technologies. Its products include Sensei Robotic Catheter System (Sensei system), Artisan Extend Control Catheter, CoHesion 3D Visualization Module and Magellan System.
Receive News & Ratings for Hansen Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hansen Medical and related companies with MarketBeat.com's FREE daily email newsletter.